Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 19, Issue 1, pp. 48-60
PubMed
Published By
Print ISSN
Online ISSN
History
- Received April 20, 2020
- Revision received July 24, 2020
- Accepted September 21, 2020
- Published first September 24, 2020.
Article Versions
- Previous version (September 24, 2020 - 05:56).
- Previous version (October 28, 2020 - 05:49).
- You are viewing the most recent version of this article.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
- Tiantian Cui1,
- Erica H. Bell1,
- Joseph McElroy2,
- Kevin Liu3,
- Ebin Sebastian1,
- Benjamin Johnson1,
- Pooja Manchanda Gulati1,
- Aline Paixao Becker1,
- Ashley Gray3,
- Marjolein Geurts4,
- Depika Subedi5,
- Linlin Yang1,
- Jessica L. Fleming1,
- Wei Meng1,
- Jill S. Barnholtz-Sloan6,
- Monica Venere1,
- Qi-En Wang1,
- Pierre A. Robe7,
- S. Jaharul Haque1, and
- Arnab Chakravarti1,*
- 1Department of Radiation Oncology, Arthur G. James Hospital/Ohio State Comprehensive Cancer Center, Columbus, Ohio.
- 2The Ohio State University Center for Biostatistics, Department of Biomedical Informatics, Columbus, Ohio.
- 3The Ohio State University College of Medicine, Columbus, Ohio.
- 4Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.
- 5Berea College, Berea, Kentucky.
- 6Department of Population and Quantitative Health Sciences and Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio.
- 7Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, the Netherlands.
- ↵*Corresponding Author:
Arnab Chakravarti, Ohio State University Comprehensive Cancer Center and Richard L. Solove Research Institute, Arthur G. James Cancer Hospital, The Ohio State University Medical School, 460 W. 10th Ave, Room D252F, Columbus, Ohio 43210. Phone: 614-293-0672; Fax: 614- 293-1943; E-mail: Chakravarti.7{at}osu.edu
January 2021
Volume 19, Issue 1
Volume 19, Issue 1
A Novel miR-146a-POU3F2/SMARCA5 Pathway Regulates Stemness and Therapeutic Response in Glioblastoma
Jump to section
Advertisement